High-throughput, high-fidelity HLA genotyping with deep sequencing

Human leukocyte antigen (HLA) genes are the most polymorphic in the human genome. They play a pivotal role in the immune response and have been implicated in numerous human pathologies, especially autoimmunity and infectious diseases. Despite their importance, however, they are rarely characterized comprehensively because of the prohibitive cost of standard technologies and the technical challenges of accurately discriminating between these highly related genes and their many allelles. Here we demonstrate a high-resolution, and cost-effective methodology to type HLA genes by sequencing, which combines the advantage of long-range amplification, the power of high-throughput sequencing platforms, and a unique genotyping algorithm. We calibrated our method for HLA-A, -B, -C, and -DRB1 genes with both reference cell lines and clinical samples and identified several previously undescribed alleles with mismatches, insertions, and deletions. We have further demonstrated the utility of this method in a clinical setting by typing five clinical samples in an Illumina MiSeq instrument with a 5-d turnaround. Overall, this technology has the capacity to deliver low-cost, high-throughput, and accurate HLA typing by multiplexing thousands of samples in a single sequencing run, which will enable comprehensive disease-association studies with large cohorts. Furthermore, this approach can also be extended to include other polymorphic genes.

[1]  N Risch,et al.  Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups. , 2001, American journal of human genetics.

[2]  Matthew W. Anderson,et al.  A multi-site study using high-resolution HLA genotyping by next generation sequencing. , 2011, Tissue antigens.

[3]  D. Monos,et al.  Next-generation sequencing: the solution for high-resolution, unambiguous human leukocyte antigen typing. , 2010, Human immunology.

[4]  H. Stephens,et al.  HLA and other gene associations with dengue disease severity. , 2010, Current topics in microbiology and immunology.

[5]  J. Todd,et al.  A genome-wide search for human type 1 diabetes susceptibility genes , 1994, Nature.

[6]  Pablo V Gejman,et al.  Genomewide linkage scan of 409 European-ancestry and African American families with schizophrenia: suggestive evidence of linkage at 8p23.3-p21.2 and 11p13.1-q14.1 in the combined sample. , 2006, American journal of human genetics.

[7]  Roanna M. Ueda,et al.  Characterization of HLA DR3/DQ2 transgenic mice: a potential humanized animal model for autoimmune disease studies , 2003, European journal of immunology.

[8]  R. S. Spielman,et al.  A genome–wide search for human non–insulin–dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2 , 1996, Nature Genetics.

[9]  F. Balloux,et al.  Pathogen-Driven Selection and Worldwide HLA Class I Diversity , 2005, Current Biology.

[10]  E. Guinan Diagnosis and management of aplastic anemia. , 2011, Hematology. American Society of Hematology. Education Program.

[11]  P. Stastny Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. , 1978, The New England journal of medicine.

[12]  James Robinson,et al.  The IMGT/HLA database , 2008, Nucleic Acids Res..

[13]  H. Luthra,et al.  HLA-DQ8 transgenic mice are highly susceptible to collagen-induced arthritis: a novel model for human polyarthritis , 1996, The Journal of experimental medicine.

[14]  Harriet Noreen,et al.  High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. , 2007, Blood.

[15]  Harriet Noreen,et al.  Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. , 2004, Blood.

[16]  J. Goedert,et al.  HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. , 1999, Science.

[17]  James R. Knight,et al.  Genome sequencing in microfabricated high-density picolitre reactors , 2005, Nature.

[18]  C Marks,et al.  Immunobiological determinants in organ transplantation. , 1983, Annals of the Royal College of Surgeons of England.

[19]  T. O’Neill HLA-B27 Transgenic Rats: Animal Model of Human HLA-B27-Associated Disorders , 1997, Toxicologic pathology.

[20]  N. Lennon,et al.  Next-generation sequencing for HLA typing of class I loci , 2011, BMC Genomics.

[21]  C. Moore,et al.  Evidence of HIV-1 Adaptation to HLA-Restricted Immune Responses at a Population Level , 2002, Science.

[22]  R Higuchi,et al.  High-resolution, high-throughput HLA genotyping by next-generation sequencing. , 2009, Tissue antigens.

[23]  Helene Polin,et al.  Rapid high-throughput human leukocyte antigen typing by massively parallel pyrosequencing for high-resolution allele identification. , 2009, Human immunology.

[24]  E. Thorsby,et al.  Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer , 1989, The Journal of experimental medicine.

[25]  J. Oksenberg,et al.  Multiple sclerosis genetics: leaving no stone unturned , 2005, Genes and Immunity.